FDA Reportedly Hopes To Fully Approve Pfizer’s Covid Vaccine


Federal regulators are aiming to grant full approval to Pfizer’s coronavirus vaccine by early September, the New York Times reported Tuesday, a step some experts believe will boost vaccinations as coronavirus cases surge nationwide.

The Food and Drug Administration internally hopes to finish the full approval process for Pfizer’s vaccine — which currently has an emergency use authorization — by Labor Day, the Times reported, citing unnamed sources.

President Joe Biden suggested last month that full approval could arrive as soon as August or as late as October.

Facebook Comments Box
READ MORE  Michelle Obama opens up about mental health struggles during Covid-19 pandemic


Please enter your comment!
Please enter your name here